Mayo Clinic Laboratory and pathology research roundup: May 2
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
Head-to-head comparison of MR elastography-based liver stiffness, fat Fraction, and T1 relaxation time in identifying at-risk NASH
The presence of at-risk nonalcoholic steatohepatitis (NASH) is associated with an increased risk of cirrhosis and complications. Therefore, noninvasive identification of at-risk NASH with an accurate biomarker is a critical need for pharmacologic therapy. We aim to explore the performance of several magnetic resonance (MR)-based imaging parameters in diagnosing at-risk NASH.
Published to PubMed This Week
- Exercise capacity, NT-proBNP, and exercise hemodynamics in adults post-fontan.
Journal of American College of Caridology - Utility of flow cytometry screening before MRD testing in multiple myeloma.
Blood Cancer Journal - Clonally selected lines after CRISPR-Cas editing are not isogenic.
CRISPR Journal - Anaplastic kaposi sarcoma: A clinicopathologic and molecular genetic analysis.
Modern Pathology - Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis.
Cell Reports. Medicine - Clinical validation of tagmentation-based genome sequencing for germline disorders.
Journal of Molecular Diagnostics - Novel initiatives are always welcome.
European Heart Journal of Acute Cardiovascular Care - Analytic result variation for high-sensitivity cardiac troponin: Interpretation and consequences.
Canadian Journal of Cardiology - Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinoma.
Human Pathology
